Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary cellulose and non-starch polysaccharides (NSPs) represent the primary constituents of dietary fiber, encompassing a diverse group of plant-derived carbohydrates that are resistant to digestion in the human small intestine (National Institutes of Health, 2023). Cellulose is a linear glucose polymer that provides structural integrity to plant cell walls, while NSPs such as pectins, hemicelluloses, and beta-glucans offer varying degrees of solubility and fermentability (British Nutrition Foundation, 2022). These compounds are essential for maintaining gastrointestinal health by increasing fecal mass and promoting regular peristalsis, thereby preventing constipation and diverticular disease (PubMed, PMID: 31296969). In the colon, they serve as substrates for fermentation by the gut microbiota, leading to the production of short-chain fatty acids (SCFAs) like butyrate, which are vital for colonocyte health and systemic metabolic regulation (World Health Organization, 2023). Clinically, high intake of these polysaccharides is associated with a reduced risk of chronic diseases, including type 2 diabetes, cardiovascular disease, and colorectal cancer. While not traditional molecular targets for small-molecule drugs, they are utilized as therapeutic bulk-forming laxatives and can significantly influence the pharmacokinetics of other medications by altering gastric emptying and intestinal transit time. Their physical properties, such as viscosity and water-holding capacity, are key determinants of their physiological effects and therapeutic utility in managing metabolic syndrome.
Dietary cellulose and non-starch polysaccharides exert their effects through several physical and chemical mechanisms. They increase stool weight and decrease transit time by retaining water and providing physical bulk in the intestinal lumen (National Institutes of Health, 2023). Soluble NSPs form viscous gels that slow the absorption of glucose and lipids, thereby improving postprandial glycemic response and lowering LDL cholesterol by sequestering bile acids (PubMed, PMID: 24876314). Furthermore, their fermentation by colonic bacteria produces short-chain fatty acids (SCFAs), which act as signaling molecules that influence appetite regulation and inflammatory pathways (World Health Organization, 2023).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary fiber (Cellulose and non-starch polysaccharides) (NSP).